Reducing Fasting Time in Children for Sedation
NCT05757882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2023-09-21
Summary
Patients are asked to be fasted for certain period of time before sedation to reduce the risk of pulmonary aspiration. However, fasting can be harmful, especially in children who has smaller reserves of energy and fluids compared to the adults. Prolonged fasting may increase nausea, vomiting, dehydration, and hypoglycemia. Therefore, it is important to minimize prolonged fasting time in pediatric patients.
This study is aimed to investigate the safety of minimal fasting time (2 hours) compared to the standard fasting time (4 hours) with gastric ultrasound.
Conditions
- Pediatric ALL
Interventions
- OTHER
-
4 hours of fasting time
Oral intake is not allowed for 4 hours before sedation including water.
- OTHER
-
2 hours of fasting time
Oral intake is not allowed for 2 hours before sedation including water.
Sponsors & Collaborators
-
Samsung Medical Center
collaborator OTHER -
Eunah Cho, MD
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Max Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-25
- Primary Completion
- 2023-08-07
- Completion
- 2023-08-07
Countries
- South Korea
Study Locations
More Related Trials
-
Feasibility of Aerodigestive Stimulation Therapy Trial
NCT06118697 ·Status: RECRUITING ·Phase: NA
-
Timing of Initiation of Parenteral Nutrition for Critically Ill Children
NCT04693143 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam
NCT01402596 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology
NCT04900597 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children
NCT04347486 ·Status: COMPLETED ·Phase: PHASE2
-
Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals
NCT05152446 ·Status: TERMINATED ·Phase: NA
-
Comparing Reversal With Neostigmine and Sugammadex in Paediatric
NCT03137290 ·Status: COMPLETED ·Phase: NA
-
LASER THERAPY IN GASTRIC STOMA INJURIES OF CHILDREN AND ADOLESCENTS
NCT04863196 ·Status: UNKNOWN ·Phase: NA
-
Prednisolone Trial in Children Younger Than 4 Years
NCT03141970 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring
NCT06867289 ·Status: RECRUITING ·Phase: NA
-
Enteral Glutamine Supplementation for the Patient With Major Torso Trauma
NCT00178581 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group
NCT06623370 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children
NCT03943888 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children
NCT04654507 ·Status: UNKNOWN ·Phase: PHASE3
-
Sucrose at Triage for Acute Gastroenteritis Episode in Children
NCT05378776 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
NCT02338440 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
NCT01075789 ·Status: TERMINATED ·Phase: NA
-
Feeding Children Nasogastrically Versus Nasojejunally While Receiving Noninvasive Positive Pressure Ventilation
NCT01301352 ·Status: COMPLETED ·Phase: NA
-
Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
NCT02044159 ·Status: COMPLETED ·Phase: PHASE4
-
Procedural Sedation for Pediatric Patients With Spinal Muscular Atrophy
NCT05291962 ·Status: COMPLETED
-
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
NCT05027308 ·Status: COMPLETED ·Phase: PHASE3
-
IV Glucose for Dehydration Treatment
NCT01285713 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis
NCT00049764 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
NCT01237288 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
NCT03563222 ·Status: TERMINATED ·Phase: PHASE4